RecruitingNot Applicable

Preimplantation Genetic Testing in Women of Advanced Maternal Age

United States240 participantsStarted 2021-03-05

Plain-language summary

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Who can participate

Age range35 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women undergoing IVF of between 35 and 40 years of age at IVF cycle start * Utilization of Intracytoplasmic Sperm Injection ICSI * Utilization of ejaculated or testicular sperm * Utilization of autologous or donor sperm * All Controlled Ovarian Hyperstimulation (COH) protocols Exclusion criteria: * Patients with anovulatory Polycystic ovarian syndrome (PCOS) * Utilization of donor oocytes * Utilization of gestational carrier * Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages * Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers

What they're measuring

Ongoing pregnancy rate

Timeframe: Up to 18 months

Trial details

NCT IDNCT04167748

SponsorGenomic Prediction Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2025-11-01

Contact for this trial

Nathan R Treff, PhD

(973) 529-4223 nathan@genomicprediction.com

View on ClinicalTrials.gov More Infertility, Female trials